Risk Factors of Mortality After Liver Transplantation in Uruguay

被引:10
作者
Olivari, D. [1 ,2 ]
Mainardi, V. [1 ,2 ]
Rando, K. [1 ,2 ]
Rey, G. [1 ]
Menendez, J. [1 ,2 ]
Prieto, J. [1 ,2 ]
Medina, J. [1 ,2 ]
Valverde, M. [1 ,2 ]
Castelli, J. [2 ]
Grecco, G. [2 ]
Leites, A. [1 ,2 ]
Zunini, G. [1 ,2 ]
Gozalez, S. [1 ,2 ]
Harguindeguy, M. [1 ,2 ]
Gerona, S. [1 ,2 ]
机构
[1] Uruguay Univ UDELAR, Hepat Biliary & Pancreat Natl Ctr, Teaching & Assistance Unit UDA, Montevideo, Uruguay
[2] Hosp Cent Fuerzas Armadas, Natl Liver Transplant Program, Montevideo, Uruguay
关键词
LONG-TERM SURVIVAL; SPANISH SOCIETY; GUIDELINES;
D O I
10.1016/j.transproceed.2017.12.036
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Introduction. Identification of predictive factors of mortality in a liver transplant (LT) program optimizes patient selection and allocation of organs. Objective. To determine survival rates and predictive factors of mortality after LT in the National Liver Transplant Program of Uruguay. Methods. A retrospective study was conducted analyzing data prospectively collected into a multidisciplinary database. All patients transplanted since the beginning of the program on July 2009 to April 2017 were included (n = 148). Twenty-nine factors were analyzed through the univariate Kaplan-Meier model. A Cox regression model was used in the multivariate analysis to identify the independent prognostic factors for survival. Results. Overall survival was 92%, 87%, and 78% at discharge, 1 year, and 3 years, respectively. The Kaplan-Meier survival curves were significantly lower in: recipients aged >60 years, Model for End-Stage Liver Disease score >21, LT due to hepatocellular carcinoma (HCC) and acute liver failure (ALF), donors with comorbidities, intraoperative blood loss beyond the median (>2350 mL), red blood cell transfusion requirement beyond the median (>1254 mL), intraoperative complications, delay of extubation, invasive bacterial, and fungal infection after LT and stay in critical care unit >4 days. The Cox regression model (likelihood ratio test, P = 1.976 e(-06)) identified the following independent prognostic factors for survival: LT for HCC (hazard ratio [HR] 4.511; P = .001) and ALF (HR 6.346; P = .004), donors with comorbidities (HR 2.354; P = .041), intraoperative complications (HR 2.707; P = .027), and invasive fungal infections (HR 3.281; P = .025). Conclusion. The survival rates of LT patients as well as the mortality-associated factors are similar to those reported in the international literature.
引用
收藏
页码:499 / 502
页数:4
相关论文
共 16 条
  • [1] Guidelines for the treatment of invasive candidiasis and other yeasts. Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). 2010 Update
    Aguado, Jose Maria
    Ruiz-Camps, Isabel
    Munoz, Patricia
    Mensa, Jose
    Almirante, Benito
    Vazquez, Lourdes
    Rovira, Montserrat
    Martin-Davila, Pilar
    Moreno, Asuncion
    Alvarez-Lerma, Francisco
    Leon, Cristobal
    Madero, Luis
    Ruiz-Contreras, Jesus
    Fortun, Jesus
    Cuenca-Estrella, Manuel
    [J]. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2011, 29 (05): : 345 - 361
  • [2] Bassetti M, 2017, TRANSPLANT DIRECT, V3, DOI 10.1097/TXD.0000000000000673
  • [3] Effect of intraoperative blood transfusion on patient outcome in hepatic transplantation
    Cacciarelli, TV
    Keeffe, EB
    Moore, DH
    Burns, W
    Busque, S
    Concepcion, W
    So, SKS
    Esquivel, CO
    [J]. ARCHIVES OF SURGERY, 1999, 134 (01) : 25 - 29
  • [4] Challenges to Liver Transplantation and Strategies to Improve Outcomes
    Dutkowski, Philipp
    Linecker, Michael
    DeOliveira, Michelle L.
    Muellhaupt, Beat
    Clavien, Pierre-Alain
    [J]. GASTROENTEROLOGY, 2015, 148 (02) : 307 - 323
  • [5] Are There Better Guidelines for Allocation in Liver Transplantation? A Novel Score Targeting Justice and Utility in the Model for End-Stage Liver Disease Era
    Dutkowski, Philipp
    Oberkofler, Christian E.
    Slankamenac, Ksenija
    Puhan, Milo A.
    Schadde, Erik
    Muellhaupt, Beat
    Geier, Andreas
    Clavien, Pierre A.
    [J]. ANNALS OF SURGERY, 2011, 254 (05) : 745 - 753
  • [6] European Liver Transplant Registry, PAT GRAFT SURV LIV T
  • [7] Grat Michal, 2013, Pol Przegl Chir, V85, P581, DOI 10.2478/pjs-2013-0087
  • [8] Hong JC, 2015, OUTCOME PREDICTORS T
  • [9] III Consensus Meeting of the Spanish Society of Liver Transplantation. Hepatitis C, living-donor liver transplantation, quality of liver grafts and of liver transplantation programs
    Ignacio Herrero, J.
    [J]. GASTROENTEROLOGIA Y HEPATOLOGIA, 2011, 34 (09): : 641 - 659
  • [10] Pretransplant mortality predictors in living and deceased donor liver transplantation
    Jo, Youn Yi
    Choi, Yong Seon
    Joo, Dong Jin
    Yoo, Young-Chul
    Nam, Seung Gyun
    Koh, Shin Ok
    [J]. JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2014, 77 (01) : 16 - 20